Microbiome biotech companies initiate experiment to study key Akkermansia strain

27 Aug 2024 — Biotech companies Pendulum Therapeutics and BiomeSense are conducting a 14-week exploratory study of a pivotal bacterial strain called Akkermansia muciniphila residing in the gut microbiome using new data generation technology.